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Abstract.  Friend erythroleukemia cells, grown in the 
presence of dimethyl sulfoxide for 3 d,  synthesize un- 
equal amounts of the two chains (a and 13) of spectrin 
with ~15-30%  more 13 than a  spectrin. When cells 
were ruptured by nitrogen cavitation, nascent a  and 13 
spectrin were found to be associated with a  membra- 
nous cell fraction and were not detected in the soluble 
cytoplasmic cell fraction. Nascent membrane-bound 
spectrin appeared not to be protected by membranes, 
since it was susceptible to trypsin degradation in the 
absence of detergent. On fractionation of cells with 
1%  Triton X-100, more (1.75-fold)  nascent spectrin was 
found in the Triton-soluble fraction than in the Triton- 
insoluble fraction (cytoskeleton). In the Triton-soluble 
fraction, there was 55 % more nascent 13 spectrin than 
a  spectrin, while the cytoskeleton contained nearly 
equal amounts of a  and 13 spectrin.  Cells were pulse- 
labeled with L-[35S]methionine for 2 min and chase in- 
cubated for varying periods of time from 15 to 90 
min with nonradioactive L-methionine. Radioactive 
spectrin accumulated in the Triton-soluble fraction 
for the first 15 min of chase incubation and then 
dropped by 25 % in the next hour. By contrast, the 
amount of radioactive spectrin in the Triton-insoluble 
fraction rose gradually for 1 h  of the chase period. 
This indicates that, in Friend erythroleukemia cells, a 
pool of membrane-bound spectrin containing an excess 
of the [3 polypeptide is used to form the cytoskeletal 
system which is composed of equal molar amounts of 
a  and 13 spectrin. The location of spectrin was deter- 
mined by immunoelectron microscopy. Small amounts 
of spectrin were detected in cells not treated with 
dimethyl sulfoxide and in these cells it was located on 
the surface membrane and within the cytoplasm. On 
treatment with dimethyl sulfoxide, complex vacuolar 
structures containing viruses appeared in the cells. In 
cells treated with dimethyl sulfoxide for 3 d  30%  of 
the spectrin was near the outer membrane and 25 % 
was associated with vacuolar structures,  whereas in 
cells treated for 5 and 7 d the majority of spectrin 
(57-61%)  was located in the vacuolar areas. 
S 
PECTRIN is  the  major component of the erythrocyte 
membrane, accounting for ~30%  of total membrane 
protein (21). It is made up of two non-identical sub- 
units,  a  (Mr 240,000)  and I] (M, 220,000),  which interact 
noncovalently  to form al3 dimers. Spectrin, together with ac- 
tin, forms part of the submembranous cytoskeletal network 
of the erythrocyte and it is connected to the plasma mem- 
brane via the protein ankyrin, which binds to the intramem- 
branous protein band 3 (9). Recently, the presence of spec- 
trin and spectrin-like proteins has been reported in numerous 
non-erythroid cells. In these cells the spectrin-like proteins 
are also found on the cytoplasmic side of  the membrane, sug- 
gesting that these proteins probably play a similar structural 
role in non-erythroid cells (2, 7,  10,  13,  14,  19, 25). 
The  synthesis  of  spectrin  and  its  assembly  into  the 
cytoskeleton has been studied in chicken erythroid cells dur- 
ing embryo differentiation (3, 4) and in dimethyl sulfoxide 
(DMSO)-treated I  Friend  erythroleukemia  cells  (FELC) 
1.  Abbreviations  used in  this paper:  DMSO, dimethyl sulfoxide; FELC, 
Friend erythroleukemia cells; STM, 0.25 M sucrose in 5 mM Tris-HCl, pH 
7.4,  1 mM MgC12. 
(12). In a previous study (24), we showed that DMSO treat- 
ment of FELC caused a staggered increase in the synthesis 
of a number of membrane proteins. Spectrin synthesis was 
maximal on the third day of DMSO treatment and declined 
thereafter, whereas the synthesis of bands 3 and 4 was in- 
creased on the fourth day and that of bands 6 and 5 on the 
fifth and sixth day of DMSO treatment, respectively. Glen- 
ney and Glenney (12) reported that in uninduced FELC both 
erythroid spectrin and non-erythroid fodrin are present at 
low levels and that their syntheses are both induced by treat- 
ment with DMSO. In this study it was also shown that FELC 
produce larger amounts of 13 spectrin than of a  spectrin. By 
contrast, chicken erythroid ceils synthesize two- to three-fold 
more  a  spectrin  than  13  spectrin  (4).  Newly  synthesized 
chicken erythroid a  and  13  spectrin  is present  in both  a 
Triton-soluble cell fraction and a Triton-insoluble cytoskele- 
ton, but in the Triton-soluble fraction there is a several-fold 
excess of a  spectrin relative to 13 spectrin, while there are 
stoichiometric amounts present in the cytoskeleton. In vitro 
translation of spectrin mRNA results in the synthesis of three 
times more a than 13 spectrin. 95 % of the in vitro-translated 
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translationally to  spectrin-depleted  rabbit  red  blood  cell 
membranes.  The  excess  nascent  tz  spectrin  remains  un- 
bound, indicating that the assembly of ¢t spectrin is limited 
by the availability of 13 spectrin (22).  A comparison of anky- 
rin synthesis to that of spectrin showed that the kinetics of 
ankyrin synthesis are similar to that of 15 spectrin (23). These 
data  suggest  that  the  assembly  of  spectrin  in  chicken 
erythroid cells is regulated by the limited amounts of 13 spec- 
trin and ankyrin. This may not, however, be the case in all 
cells, since FELC appear to produce more 15 than ¢t spectrin 
(2). 
In chicken erythroid cells, excess ankyrin and ¢t and 13 
spectrin,  present  in  the  Triton-soluble  pool,  are  rapidly 
catabolized. This is in contrast to nascent ankyrin and spec- 
trin which is assembled into the cytoskeleton and shows no 
detectable turnover (23). This has led to the alternate sugges- 
tion that the assembly of cytoskeletal proteins is regulated by 
the availability of protein  receptors  and that the ultimate 
receptor is the anion transport protein (band 3) which is an 
integral component of the plasma membrane (18). 
To clarify the mechanisms of spectrin assembly we have 
studied, at a time of maximal spectrin production by FELC 
(3 d of DMSO treatment), the rate of synthesis of a  and 13 
spectrin,  the intracellular location of the nascent spectrin 
chains, and their insertion into the cytoskeletal network. 
Materials and Methods 
Ce//s 
Friend erythroleukemia cells (FELC), line 745, were maintained in suspen- 
sion as described earlier (24). To induce differentiation, cells were seeded 
at  a  density of 5  x  104  cells/ml and  grown in  the presence of  1.8% 
(vol/vol) DMSO for 3 d. The cells were a kind gift from Dr. A. O. Pogo, 
New York Blood Center, who obtained them from Dr. C. Friend (Center 
for Experimental Cell Biology,  Mount Sinai School of Medicine, New 
York). 
Preparation of  Spectrin and Spectrin Antibodies 
Spectrin was purified from mouse erythrocyte membranes by slight modifi- 
cations to the method of Ungewickell and Gratzer (28). Briefly,  mouse red 
blood cells were lysed in 5 mM sodium phosphate, pH 8.0, extracted with 
0.3 mM sodium phosphate, pH 7.6, containing 100 U/ml Trasylol (Aproti- 
nin, FBA Pharmaceuticals, New York, NY) for 20 min at 370C, followed 
by centrifugation at 80,000  g  for 30 min. The supernate, which consists 
mainly of spectrin and actin, was concentrated by ultrafiltration, and then 
further purified on a Sepharose 4B column. Purified spectrin was coupled 
to CNBr-activated Sepharose 4B, and used for the purification of spectrin 
antibody. 
To prepare spectrin antibody, the concentrated proteins in the 80,000 g 
supernate were separated by gradient (5-16%) PAGE. The ¢t and 13 bands 
of spectrin were excised from the gels, homogenized with a small amount 
of water using a  Brinkmann Polytron, mixed with an equal  volume of 
Freund's complete adjuvant (Miles Laboratories, Inc., Elkhart, IN) and in- 
jected into rabbits subcutaneously for several weeks at weekly intervals. Af- 
ter a positive response was obtained, serum was collected. It was found that 
sera from both rabbits injected with either the ¢t or the 13 band reacted with 
both bands of spectrin. The sera were therefore combined and spectrin anti- 
body was purified by affinity chromatography using spectrin coupled to 
CNBr-activated  Sepharose 4B  (Pharmacia  Fine Chemicals,  Piscataway, 
N J).  The  antibody thus  purified precipitated  only  radioactive  spectrin 
(bands ~t and 13) from whole cell homogenates of FELC which have been 
metabolically labeled with L-[35S]methionine.  The amount of antibody re- 
quired to  quantitatively  immunoprecipitate 10  Ixg of mouse erythrocyte 
spectrin was determined by titration and based on this a slight excess was 
used in the immunoprecipitation of spectrin from FELC. 
Radioactive ~eling 
Cells  were washed several times with phosphate buffered saline  (PBS) 
(10  mM  NaPO4,  pH  7.4,  140  mM  NaC1)  and  then were suspended at 
1  x  107  cells/ml in  methionine-free minimal  essential  medium  (Flow 
Laboratories, Inc., McLean, VA) supplemented with 10% fetal calf serum. 
In continuous labeling experiments, cells were preincubated at 37°C for 
15-20 rain before the addition of 10-20 IxCi/mi  L-[33S]methionine  (>800 
Ci/mmol; New England Nuclear,  Boston, MA).  In pulse-chase incuba- 
tions,  100  I~Ci/ml  of L-[35S]methionine  was used and at the end of the 
pulse period 1 mM of unlabeled methionine was added. All incubations 
were carried out at 37°C with gentle mixing of cell suspensions. At various 
times, aliquots were taken and the samples were processed as described 
below. 
Cell Fractionation 
All solutions used in cell fractionation contained protease inhibitors at the 
following concentrations: 200 U/ml Trasylol, 1 mM phenylmethylsulfonyl 
fluoride (Calbiochem-Behring Corp., San Diego, CA), and 0.1 mM L-l-to- 
sylamide-2-phenylmethylchloromethyl ketone (Sigma Chemical Co.,  St. 
Louis, MO). All operations were carried out at 4°C. 
(a) Membranous  and Soluble  Cytoplasmic  Cell Fracffons.  After incu- 
bation with L-[3SS]methionine, cells were washed several times with 0.25 M 
sucrose in 5 mM Tris-HC1,  pH 7.4,  1 mM MgC12 (STM) and resuspended 
in STM at 1-10 x  107 cells/ml. Cells were lysed by nitrogen cavitation at 
400 psi for 10 min. Lysed cells were centrifuged at 105,000 g for 30 rain 
in order to obtain a membranous pellet and a soluble cytoplasmic supernate. 
To obtain other cell fractions, lysed cells were centrifuged at 480 g for 10 
min, at 9,750 g for 10 min, and at 105,000 g for 30 rain. When membranes 
were treated with trypsin, protease inhibitors were omitted from the solu- 
tions. 
(b) Triton-soluble and -insoluble  (Cytnskeletal)  Cell Fractions.  Cyto- 
skeletal and Triton-soluble fractions were prepared by treatment of cells 
with Triton X-100 as described by Cervera et al. (8). After incubation with 
L-[35S]methionine,  cells were washed with PBS, pH 7.4,  and gently sus- 
pended in extraction buffer (10 mM Pipes, pH 6.8,  1(30 mM KCI, 2.5 mM 
MgC12, 0.3 M sucrose). Triton X-100 was added to a final concentration of 
1% and the samples were placed on ice for 3 min. The samples were then 
centrifuged at 1,200 g for 3 min, the resulting pellets were washed once with 
extraction buffer containing 1% Triton X-100, and the supernatant fractions 
were combined (Triton-soluble fraction). The insoluble material contains 
the bulk of the cytoskeletal fraction. 
Protease Treatment of  the Membrane Fraction 
The membrane fractions were suspended in STM and aliquots were in- 
cubated with and without trypsin (0.5 mg/ml), in the presence and absence 
of 1% Triton X-100, at room temperature for 20 min. The incubation was 
stopped by the addition of SDS to a final concentration of 2 % and by heating 
at 100°C for 3 rain. The spectrin present in the samples was immunoprecipi- 
tated as described below. 
Immunoprecipitation 
Cells (2-5  x  107) or cell fractions were suspended in 200-250  txl of 2% 
SDS and heated at 100°C for 3 min to dissolve proteins. The samples were 
then diluted to 0.1%  SDS by the addition of NET buffer (150 mM NaCl, 
5 mM EDTA, 50 mM Tris-HC1,  pH 7.4, 0.02%  sodium azide) containing 
0.5% Triton X-100, 300 U/ml Trasylol, 1 mM phenylmethylsulfonyl fluo- 
ride, and 0.1 mM L-l-tosylamide-2-phenylmethylchloromethyl  ketone. Par- 
ticulate material was removed by centrifugation at 12,000 g for 10 rain and 
the supernates were carefully decanted and used for the immunoprecipita- 
tion of spectrin. Affinity-purified anti-spectrin (60 Ixl) was added and sam- 
pies were incubated overnight at 4°C with gentle shaking. Immunoprecipita- 
tion was aided by the addition of 100 Ixl of 100 mg/ml Protein A-Sepharose 
CL-4B (Pharmacia Fine Chemicals) and the samples were incubated for an 
additional 2-3 h at 40C.  Samples were centrifuged and the Protein A-im- 
mune complex was washed six times with NET buffer containing 0.1% SDS, 
0.5 % Triton X-100, and 300 U/ml Trasylol. The immune complex was eluted 
from protein A-Sepharose by heating at 100°C for 3 min with electrophore- 
sis sample buffer (0.34  M  Tris-phosphoric acid, pH 6.7, containing 6  M 
urea,  7.1  mM  EDTA,  71  mM dithiothreitol, and 2.85%  SDS).  Protein 
A-Sepharose was removed by centrifugation and the radioactivity in an ali- 
quot of the supernatant fraction was determined to measure total spectrin 
The Journal  of Cell Biology,  Volume 103, 1986  104 radioactivity. The remainder of the supernatant fraction was subjected to 
SDS PAGE to obtain the radioactivity of the separated ct and 13 spectrin 
chains. 
Electrophoresis and Fluorography 
Proteins were analyzed by electrophoresis on SDS polyacrylamide slab gels 
according ~  the method of Maizel (20). Gels contained 5-16% acrylamide 
gradients with a 3.75 % acrylamide stack. Radioactive proteins were located 
by fluorography (5, 17) and the radioactive areas of the gel were excised and 
solubilized by heating at 70-75°C for 3 h with 20% perehloric acid and 20% 
hydrogen peroxide. The samples were cooled to room temperature before 
the addition of Scinti Verse II (Fisher Scientific Co., Pittsburgh, PA). Radio- 
activity was determined by liquid scintillation spectrometry. 
Amino Acid Analysis 
ct and 13 spectrin from mouse red cell membrane extracts were eluted from 
SDS polyacrylamide gels according to the method of Hager and Burgess 
(16). The proteins were precipitated with acetone and hydrolyzed in 6 N 
HCI. Amino acid composition was determined in a Beckman amino acid 
analyzer 6300 using ninhydrin reaction program No.  1 (Beckman Instru- 
ment Co., Palo Alto, CA). 
Electron Microscopy 
Cells or Cell fractions were fixed in suspension with 2% glutaraldehyde in 
0.1 M  sodium eacodylate-HCi buffer, pH 7.4 for 30 rain at 4°C, followed 
by  centrifugation.  The  pellets obtained were postfixed with  1%  OsO4, 
stained with 2% uranyl acetate, dehydrated in graded ethanol, and embed- 
ded in Epon 812. Thin sections were obtained using a Sorvall Porter-Blum 
MT2-B ultmmicrotome. Sections were stained with uranyl acetate and lead 
citrate and examined in a  Philips 410 microscope. 
lmmunocytochemistry 
The cells were processed for electron microscopy, embedded in Lowicryl 
K4M  and  immunochemically  labeled  as  described  by  Bendayan  (1). 
Affinity-purified  rabbit anti-spectrin, diluted 1:10 or 1:50 with PBS contain- 
ing 1% bovine serum albumin, was the first antibody used and in the second 
step goat anti-rabbit IgG coupled to 20-nm colloidal gold particles (Janssen 
Life Science, Piscataway,  N J) was used. We performed two immunocyto- 
chemical controls: (a) incubation of the tissues with non-immune rabbit se- 
rum  instead of anti-spectrin, and  (b)  incubation  of the tissue  sections 
directly with goat anti-rabbit IgG gold complex. 
Other Methods 
Western immunoblots, using afffinity-purified anti-spectrin or a rabbit anti- 
body against mouse fodrin (generously provided by Dr. J. Glenney, Salk In- 
stitute for Biological Sciences, San Diego, CA) were performed according 
to  the  method of Bnrnette  (6).  [nsI]-labeled protein A  (>30  mCi/mg, 
Amersham Corp., Arlington Heights, IL) was used as a  second reagent. 
Radioactive areas were detected by autoradiography. 
Mouse brain membranes were prepared and demyelinated by the method 
of Goodman et al.  (15). 
Results 
Amino Acid Composition of  a and[3 Spectrin 
The biosynthesis of the individual chains of spectrin was 
measured by following the incorporation of L-[35S]methio- 
nine into the isolated proteins. It was therefore necessary to 
determine the L-methionine content of these polypeptides. 
The amino acid composition of mouse erythrocyte spectrin 
in mole % is shown in Table I. Both ct and 13 spectrin contain 
similar amounts of L-methionine: 1.7 moles % in the ct chain 
and 1.4 moles % in the 13 chain. The composition of  the other 
amino acids in the a  and 13 chains is similar with perhaps [3 
spectrin containing a larger mole % of proline and lysine. In 
Table L Amino Acid Composition of  a and [J Spectrin 
(in mole %) 
Human 
Amino Acid  a  Spcctrin  13 Spectrin  Spectrin  (21) 
Asp  13.0  11.0  10.8 
Thr  5.3  5.8  3.9 
Ser  10.2  8.0  5.2 
Glu  18.0  16.2  20.1 
Pro  1.6  4.6  2.1 
Ala  9.0  7.8  9.3 
Val  4.8  6.0  4.8 
Met  1.7  1.4  1.1 
lie  4.2  3.2  3.5 
Leu  11.0  11.1  14.2 
Tyr  3.0  3.2  2.1 
Phe  3.8  4.0  3.4 
His  3.0  2.6  3.0 
Lys  5.0  9.0  7.1 
Arg  6.2  5.8  6.4 
Gly  ND*  ND*  4.7 
*  The content of glycine in ¢t and 13 spectrin was not determined, because the 
proteins were eluted from gels run in Tris-glycine buffer. Some of the glycine, 
present in the buffer, was retained during the isolation of spectfin and yielded 
artificially  high levels of glyeine. 
addition,  the composition of mouse spectrin is  strikingly 
similar to that of human erythrocyte spectrin (21),  whose 
amino  acid  composition is  included  in  Table I  for com- 
parison. 
Synthesis of a and ~ Chains of  Spectrin 
The studies on the biosynthesis of spectrin were all per- 
formed on cells grown in the presence of DMSO for 3 d, 
since previously we have shown that this is a time of maximal 
spectrin production (24). To study the rate of synthesis of the 
individual ~t and 13 spectrin polypeptides, the cells were in- 
cubated with L-[35S]methionine at 37°C for varying periods, 
from 15 min to 2 h, and the incorporation of radioactivity 
into a  and 13 spectrin was measured. During the incubation 
period there was a near linear, increasing amount of incorpo- 
ration of radioactivity into both a  and  13  spectrin.  At all 
times, however, there were unequal amounts of radioactivity 
in the two spectrin chains with a 15-30% excess of 13 chain 
radioactivity (Fig.  1).  This indicates that there is unequal 
synthesis of the two spectrin chains with a greater amount 
of 13 chain being produced. 
Specificity of Spectrin Antibody 
FELC contain both spectrin and non-erythroid fodrin (12). 
To ascertain that the spectrin antibody used in these studies 
did not react with fodrin, it was tested by Western immuno- 
blotting of mouse brain membrane proteins which contain 
fodrin but not spectrin. As shown in Fig. 2, the antibody to 
spectrin  reacted with  proteins  from FELC  but  not  from 
mouse  brain  membranes.  As  a  control,  antibody  against 
mouse fodrin was also tested in this system and it reacted 
with fodrin from both FELC and mouse brain membranes. 
Thus, FELC contain fodrin but the spectrin antibody does 
not react with it. 
Intracellular Location of Nascent Spectrin 
To determine the cellular location of nascent spectrin, FELC 
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Figure 1.  L-[ssS]methionine  incorporation into a  and 13 spectrin. 
(A) FELC, at a concentration of 1  ×  107 cells/ml in methionine- 
free medium with  10%  fetal calf serum,  were incubated with  L- 
[3SS]methionine (10 IxCi/ml)  for 2 h at 37°C.  Aliquots were taken 
at 15, 30, 60,  90,  and  120 min, cells were washed with PBS,  and 
heated with 2 % SDS for 3 min at 100°C. Spectrin was isolated by 
immunoprecipitation, followed by SDS PAGE and fluorography.  A 
portion of the fluorogram is shown. (B) The a  and 13 bands of spec- 
trin were excised from the gel shown in the above fluorogram. The 
gel slices were solubilized and the radioactivity in each band was 
determined. (o) Radioactivity in I~ spectrin; (o) radioactivity in a 
spectrin. 
were  disrupted  by  nitrogen  cavitation  and  fractionated 
into  a  membranous  pellet  (material  which  sedimented  at 
105,000  g)  and  soluble  cytoplasmic  cell  fraction.  Spectrin 
was isolated from both of these cell fractions by immunopre- 
cipitation,  followed by SDS PAGE and fluorography.  At all 
times  during  a  3-h  incubation  with  L-[3SS]methionine, 
radioactive spectrin was found to be associated only with the 
105,000 g pellet, and was not found in the cytoplasmic frac- 
tion  (Fig.  3). 
Figure 2. Specificity of spectrin antibody.  Proteins from the Triton- 
insoluble fraction of FELC and from mouse brain membranes were 
separated by SDS PAGE and analyzed by Western immunoblotting 
using either spectrin antibody or a rabbit antibody against mouse 
fodrin,  followed by [t2sI]-labeled  protein A. An autoradiogram is 
shown. (Lane 1) Mouse brain membrane proteins probed with anti- 
spectrin; (lane 2) FELC proteins probed with anti-spectrin; (lane 
3) mouse brain membrane proteins probed with anti-fodrin; (lane 
4) FELC proteins probed with anti-fodrin. 
The  membranous  material  was  subfractionated  by  dif- 
ferential  centrifugation  into  fractions  which  sedimented  at 
480 g  in  10 min,  9,750 g  in  10 min,  and at  105,000 g  in 30 
min,  Radioactive  spectrin  was present in all of these  frac- 
tions with ,~37 % of the total spectrin in the homogenate re- 
covered in the 480 g  fraction,  24%  in the 9,750 g  fraction, 
and 34 % in the 105,000 g pellet. Electron microscopy of the 
isolated  cell  fractions  showed that the 480 g  fraction  con- 
tained unbroken cells, nuclei,  and some membranous mate- 
rial,  and the 9,750 g  fraction was enriched  in mitochondria 
but  also  contained  other  membranous  organelles.  The 
105,000  g  fraction was the most homogeneous  (see Fig.  4) 
and consisted of a mixture of closed membrane vesicles and 
vesicles with attached polysomes. Some free polysomes and 
lysosomes were also apparent. 
To  determine  whether  nascent  spectrin  was  contained 
within the membranous vesicles or was associated with the 
outer  surface  of the  membrane,  the  samples  were  treated 
with trypsin (0.5 mg/ml) in the presence and absence of 1% 
Triton  X-100.  Nascent  spectrin  was  susceptible  to  trypsin 
degradation even in the absence of Triton X-100 (Fig.  5), in- 
dicating  that  although  it  is  associated  with  the  membrane 
vesicles it does not appear to be protected by them; this sug- 
gests that spectrin is not found inside the membranous vesi- 
cles but is associated  on the outer  surface. 
Nascent a and ~ Spectrin in Triton-soluble 
and -insoluble Cell Fractions 
FELC  were also fractionated  in the presence of 1%  Triton 
Figure 3.  Nascent spectrin in soluble cytoplasmic and membrane 
cell fractions. FELC were incubated with L-[3sS]methionine as de- 
scribed in legend to Fig.  1. At various times from 15 to  180 min, 
aliquots were taken, cells were washed with STM,  and lysed by 
nitrogen cavitation at 400 psi for  10 min.  Lysed cells were cen- 
trifuged at 105,000 g for 30 rain in order to obtain a soluble cytoplas- 
mic and a membranous cell fraction. Spectrin from these cell frac- 
tions was isolated by immunoprecipitation, followed by SDS PAGE 
and fluorography.  (Lanes 1-6) Spectrin in the membrane fraction 
(105,000 g pellet) at 15, 30, 60, 90,  120, and 180 min. (Lanes 7-12) 
Spectrin in the soluble cell fraction at the same time points as those 
described above. 
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trypsin.  A 105,000 g pellet was prepared as described in legend to 
Fig. 3 and the material was suspended in STM. Aliquots were in- 
cubated with and without trypsin (0.5 mg/ml) in the absence and 
presence of 1% Triton X-100 for 20 rain at room temperature. Incu- 
bations were terminated by heating at 100°C for 3 min in the pres- 
ence of 2 % SDS. Spectrin was isolated by immunoprecipitation and 
SDS PAGE, followed by fluorography. Lane I shows the radioactive 
¢t and I~ spectrin bands from samples not treated with trypsin nor 
detergent; lane 2, that treated with trypsin in the absence of deter- 
gent; lane 3, that treated with detergent but not with trypsin;  and 
lane 4, that treated with both trypsin and detergent. 
Figure 4. Electron micrograph of the 105,000 g (membrane) pellet. 
FELC, labeled  for 30 min with L-[3SS]methionine, were lysed as 
described in legend to Fig. 2. Lysed cells were centrifuged at 480 g 
and  9,750 g  to eliminate  nuclei  and  mitochondria  and  the post- 
mitochondrial  supernate was centrifuged at 105,000 g for 30 min. 
The electron micrograph shows the material in the 105,000 g pellet. 
Bar, 250 nm. 
X-100  in order to  study the distribution  of spectrin in the 
cytoskeletal (Triton-insoluble) and Triton-soluble cell frac- 
tions. The morphology of untreated cells and cells extracted 
with 1% Triton X-100 is shown in Fig. 6. The untreated cells 
contain a typically large nucleus, and the cytoplasm, which 
is surrounded by an intact plasma membrane, contains well- 
defined  mitochondria,  endoplasmic  reticulum,  and  many 
free ribosomes.  Treatment with Triton X-100  depletes the 
cytoplasm of organelles  and  an  amorphous  insoluble  net- 
work,  presumably  the  cytoskeletal  system,  accumulates 
around the nucleus. 
Cells were incubated with  L-[35S]methionine  for various 
periods of time up to 2 h and then fractionated with Triton 
X-100  into  a  cytoskeletal  (Triton-insoluble)  and  a  Triton- 
soluble fraction. At all times, there was 50-75 % more radio- 
active spectrin in the Triton-soluble than in the cytoskeletal 
fraction (Fig. 7).  In addition,  the ratios of the two spectrin 
bands (ct and 15) were found to be markedly different in these 
cell  fractions.  The  nascent  spectrin  in  the  Triton-soluble 
fraction contained more radioactive 15 spectrin than et spec- 
trin (Fig. 8), while in the cytoskeletal cell fraction the radio- 
activities in the two spectrin bands were similar (Fig. 9) or 
contained a slight excess of radioactive a  spectrin. The aver- 
age ratios of radioactive ct to 13 spectrin from several experi- 
ments were 0.74  +  0.16 in the  Triton-soluble fraction and 
1.17 +  0.26 in the cytoskeletal fraction. 
To determine whether or not nascent spectrin moved, with 
time, from one cellular compartment to another, FELC were 
pulse-labeled  for  2  min  with  L-[35S]methionine  and  then 
were chase  incubated with  nonradioactive methionine  for 
various periods of time up to 90 rain. At each time point the 
cells were fractionated into a cytoskeletal and a Triton-solu- 
ble fraction and the radioactivity of spectrin in each fraction 
was determined. At the end of the 2-rain pulse incubation, 
the  immunoprecipitate  contained  radioactive  incomplete 
spectrin polypeptide chains. This was noted especially in the 
Triton-insoluble fraction.  During the chase period,  the in- 
complete polypeptide chains disappeared and radioactivity 
was detected in completed tz and 13 bands of spectrin. During 
the first 15 min of the chase period, there was a rapid three- 
fold  increase  of radioactive  spectrin  in  the  Triton-soluble 
fraction followed by a 25 % decrease in the subsequent chase 
periods. Radioactive spectrin was also quickly incorporated 
into the Triton-insoluble fraction, but it did not reach maxi- 
mal incorporation into this fraction until 60 min of the chase 
period. At all time points, there was more radioactive spec- 
trin in the Triton-soluble than in the Triton-insoluble frac- 
tion.  The  kinetics  suggest  that  nascent  spectrin  quickly 
enters a Triton-soluble fraction and then a portion of it is in- 
corporated into a cytoskeletal fraction.  At the end of a 90- 
min chase period,  •65  % of the pulse-labeled spectrin re- 
mained in the Triton-soluble fraction (Fig.  10). 
An analysis of the amounts of radioactive a  and 13 spectrin 
in  the  cytoskeletal  and  Triton-soluble  fraction  at  various 
times of the chase period showed that at all times there was 
*14%  more radioactive 13  spectrin than  et  spectrin in  the 
Triton-soluble fraction.  The reverse occurred  in  the cyto- 
skeletal fraction which contained 35 % more radioactive et 
Pfeffer et al. Biosynthesis of Spectrin  107 Figure 6. Electron micrograph of cells treated with Triton X-100. FELC were extracted with 1% Triton X-100 and prepared for electron 
microscopy as described in Materials and Methods. (A) Untreated FELC; (B) Triton-treated FELC. Bar, 1,000 nm. 
than I] spectrin (Fig. 10). This unequal distribution of radio- 
active ¢t and  I] chains,  in the Triton-soluble and insoluble 
fractions in pulse-chase conditions, confirms the existence of 
a larger amount of I~ spectrin in the Triton-soluble fraction 
and also suggests that some of the pool of preformed 13 spec- 
trin  is  incorporated  in  the  cytoskeletal  system  since  the 
specific radioactivity of the 13 chain is less than that of the 
¢t chain. 
lntraceUular  Pools of a and fl Spectrin 
Further evidence that there is an excess of 13 spectrin in the 
Triton-soluble pool was obtained by labeling cells for 18 h 
with L-[35S]methionine.  Equilibration of protein radioactiv- 
ity occurs after such a long-term incubation. The amount of 
radioactive ~t and [~ spectrin in the cell homogenate and in 
Triton-soluble and -insoluble fractions was determined (Fig. 
11). There was more I~ than a spectrin in the cell homogenate 
and the Triton-soluble fraction but there were near equal 
amounts in the Triton-insoluble fraction. The ratio of a  to 
13 spectrin in the cell homogenate was 0.85,  in the Triton- 
soluble fraction 0.74,  and  in  the Triton-insoluble fraction 
1.06. 
Immunocytochemical Location of  Spectrin in 
Untreated and DMSO-treated FELC 
As previously described by others, using indirect immuno- 
fluorescent (11, 26)  and biochemical (24)  methods,  small 
amounts  of  spectrin  are  detectable  in  uninduced  cells 
and DMSO treatment causes an accumulation of spectrin. 
This  was  confirmed by  immunocytochemistry (Table II). 
After 3 d  of DMSO treatment there is a  3.5-fold increase 
in the amount of spectrin  and the amounts decline by al- 
most 35% after 5 to 7 d (Table II). At 3 d of DMSO treat- 
ment, 30% of the spectrin is localized near the outer plasma 
membrane of the cell and the majority (26%) of the remain- 
ing spectrin is found throughout the cytoplasm but preferen- 
tially  concentrated (25%)  in  complex vacuolar structures 
which contain virus particles. These vacuolar structures are 
induced by DMSO treatment and do not appear in untreated 
cells (27).  After 5  to 7  d  of DMSO treatment, there is  a 
The Journal of Cell Biology,  Volume 103, 1986  108 marked increased amount of spectrin (57-61%) in these
vacuo]ar structures (see Table 11 and Fig. 12) but substantial
amounts (17-21%) also remain associated with the surface
membrane .
Discussion
The two polypeptides of spectrin, a and ß, are synthesized
by FELL in unequal amounts, with more (15-30%) radioac-
tive methionine being incorporated into the ß chain as com-
pared to thea chain. Similar results were recently reported
by Glenney and Glenney (12) with uninduced and DMSO-
induced FELC incubated overnight with L-[35S]methionine .
Thus spectrin synthesis by FELC is different from that of
ó
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Figure 7 . Time course of L-[35S]methionine incorporation into
Triton-soluble and Triton-insoluble spectrin . FELC were incubated
with L-[35S]methionine as described in legend to Fig . 1 . At various
times cells were fractionated into a Triton-soluble and -insoluble
(cytoskeletal) fraction (see Materials and Methods) . Radiolabeled
spectrin was isolated from both fractions by immunoprecipitation
followed by SDS PAGE . (o) Radioactivity of spectrin in Triton-
soluble fraction . (e) Radioactivity of spectrin in Triton-insoluble
fraction .
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Figure 8 . Time course of incorporation of L-[35S]methionine into
a and ß spectrin of the Triton-soluble fraction . FELC were in-
cubated with L-[35S]methionine for 15, 30, 60, 90, and 120 min and
then fractionated into Triton-soluble and Triton-insoluble (cyto-
skeletal) fractions as in Fig. 6 . The radioactivity of spectrin isolated
from the Triton-soluble fraction is presented . (A) Fluorogram of ra-
diolabeled spectrin obtained at 15, 30, 60, 90, and 120minfrom the
Triton-soluble compartment . (B) The a and ß bands of spectrin
were excised from the gelshown inthe above fluorogram . Gel slices
were solubilized and the radioactivity in each band wasdetermined .
(o) Radioactivity of a spectrin ; (9) radioactivity of ß spectrin .
avian erythroid cells . In avian erythroid cells, there is also
unequal synthesisof thetwo spectrin chains, but several-fold
more a than ß chains are produced (4) .
Both avian erythroid cells and FELC contain a larger
amount of newly synthesized spectrin in the Triton-soluble
fraction than in the cytoskeletal (Triton-insoluble) cell frac-
tion . However, the Triton-soluble fraction ofFELC contains
more radioactive ß than a spectrin, while that of the avian
erythroid cells contains more a thanß chain (4) . Acommon
feature is that in the cytoskeletal fraction of both FELC and
avian erythroid cells, the two spectrin chains are present in
near equal amounts.
TheFELC appears to contain a large pool of both a andB
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Figure 9 Time course ofincorporation of 1.-[35S]methionine into a
and ß spectrin of the Triton-insoluble fraction. FELC were in-
cubated with r.-["S]methionine for various times from 15 to 120
min and fractionated into Triton-soluble and Triton-insoluble frac-
tions as described in legend to Fig. 6. The radioactivity of spectrin
in the Triton-insoluble (cytoskeletal) fraction is presented . (A)
Fluorogram of radiolabeled spectrin at 15, 30, 60, 90, and 120 min .
(B) The a and ß bands of spectrin were excised from the gel shown
in the above fluorogram . Gel slices were solubilized and the radio-
activity in each band was determined . (o) Radioactivity of a spec-
trin ; (e) radioactivity of ß spectrin .
ß spectrin in the noncytoskeletal (Triton-soluble) fraction.
1,-[35S]methionine continues to be incorporated into the Tri-
ton-soluble fraction for 90 to 120 min (Figs . 7 and 8) . On
the other hand, the incorporation ofnascent spectrin into the
cytoskeletal fraction is only linear for 1 h (Figs. 7 and 9) . The
pulse-chase experiments also indicate that FELC contain a
large pool of noncytoskeletal spectrin . At 90 min of the chase
period, 65% of the pulse-labeled spectrin remains in the
Triton-soluble fraction and it is comprised of both a and ß
spectrin (Fig . 10) . This is different from the avian erythroid
cell which has a large (threefold) molar excess ofa to ß spec-
trin in the Triton-soluble fraction and thus during a chase in-
cubation all ofthe nascent ß spectrin is incorporated into the
cytoskeletal fraction and the excess a spectrin remains in the
Triton-soluble fraction (23) . The Triton-soluble fraction of
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FELC does not have a several-fold excess of one chain and
thus during the chase period this fraction retains a substantial
amount of both a and ß spectrin . That there is a greater pool
of ß spectrin in the Triton-soluble fraction and that the
cytoskeleton contains equimolar amounts ofa and ß spectrin
is reflected in the radioactive composition of spectrin in the
cytoskeleton . In a continuous labeling experiment (Fig . 9)
there are near equal amounts of radioactive a and ß chains
in the cytoskeleton, yet in a pulse-chase experiment, the
chase-labeled cytoskeletal fraction contains more a spectrin
a
CHASE TIME (min)
Figure 10. Pulse-chase incubation : appearance of radiolabeled
spectrin in the Triton-soluble and Triton-insoluble fractions . FELC
were pulse-labeled with 1 .-[35S]methionine (100 pCi/ml) for 2 min,
followed by a chase incubation in the presence ofunlabeled methio-
nine (1 mM) . Cells were taken at 0, 15, 25, 60, and 90 min of chase
incubation, fractionated with 1% Triton X-100 into Triton-soluble and
Triton-insoluble fractions, and spectrin was isolated as described in
Materials and Methods . (A) A fluorogram of radioactive spectrin
in the Triton-soluble and -insoluble fraction at the end of the pulse
period (0) and at various chase intervals from 15 to 90 min . (B)
Spectrin was excised from the gel shown in the above fluorogram
and the amount of radioactivity in each chain from both cell frac-
tions was determined by liquid scintillation spectrometry. (Sa) Ra-
dioactivity of a spectrin from the Triton-soluble fraction ; (Sß)
radioactivity of ß spectrin from the Triton-soluble fraction ; (Ca)
radioactivity of a spectrin from the cytoskeletal (Triton-insoluble)
fraction ; (Cß) radioactivity of ß spectrin from the cytoskeletal
fraction .Figure  11.  Intracellular  pools 
of ¢t  and  13  spectrin.  FELC 
were incubated with  L-[35S] 
methionine  (10  I~Ci/ml) for 
18 h. Radioactive  spectrin was 
isolated from the cell homoge- 
nate, Triton-soluble, and Triton-insoluble fractions. An autoradio- 
gram of ¢t and I~ spectrin is shown. (Lane 1 ) Spectrin in homoge- 
nate; (lane 2) spectrin in Triton-insoluble  fraction; (lane 3) spectrin 
in Triton-soluble fraction. 
radioactivity (Fig.  10). This is to be expected if there are 
stoichiometric amounts of ct and I~ spectrin in the cytoskele- 
ton and the precursor pool in the Triton-soluble fraction con- 
tains an a  spectrin of higher specific radioactivity. A higher 
¢t spectrin-specific radioactivity in the Triton-soluble pool 
is the result of the unequal and excessive production of I~ 
spectrin  which  leads  to  an  accumulation,  in  the  Triton- 
soluble fraction, of unlabeled 13  spectfin before the pulse 
period and during the chase incubation (see Figs. 1 and 8). 
The occurrence of a greater pool of 13 spectrin in the Triton- 
soluble fraction was confirmed by incubating cells for 18 h 
with L-[35S]methionine,  a  time at which a  steady state of 
protein  radioactivity has  been  achieved,  and determining 
that there was an excess of I~ spectrin in the Triton-soluble 
fraction  and  equal  amounts  of a  and  13  spectrin  in  the 
cytoskeletal fraction (Fig.  11). 
Since the amount of ct and 13 spectrin was determined by 
measuring the radioactivity in the protein bands separated by 
SDS PAGE, there is a danger that proteolytic products from 
a  spectrin may co-electrophorese with I~ spectrin. This is 
possible, but doubtful, since equal amounts of ¢t and 13 spec- 
trin radioactivity are obtained in the Triton-insoluble frac- 
tion. For proteolysis to distort the measured ratio of a  to 13 
spectrin,  there  would have to be more proteolysis in the 
Triton-soluble fraction than in the Triton-insoluble fraction. 
The nature of the pool of spectrin in the Triton-soluble 
fraction is unclear. It is not soluble in the absence of deter- 
gents, but appears to be bound to a variety of different mem- 
branous organelles. Yet this pool of spectrin does not appear 
to be enclosed by the membranous organelles since treatment 
with trypsin in the absence of detergents digests the nascent 
spectrin. We do not know, however, whether in the intact cell 
this pool of spectrin is attached to the membranes or whether 
it  is  part  of a  cytoplasmic structure  that is  disrupted by 
homogenization, is insoluble in aqueous solutions, and binds 
nonspecifically to  the  outer  surface  of membranous  or- 
ganelles. If the noncytoskeletal spectrin is part of a cytoplas- 
mic structure, it is distinct from the cytoskeleton since it is 
disrupted by 1% Triton X-100 and its composition of radioac- 
tive a  and 13 spectrin differs from that of the cytoskeleton. 
Whatever the nature of spectrin in the Triton-soluble frac- 
tion, our studies clearly indicate that it is not a pool of %olu- 
blC spectrin since disruption of the cells in the absence of 
detergents  shows that the  nascent spectrin  is  attached to 
sedimentable cell structures. 
Nascent incomplete spectrin chains are noted at the end of 
a 2-min pulse incubation in both the Triton-soluble and the 
Triton-insoluble fractions. These incomplete chains are more 
prominent in the Triton-insoluble fraction (Fig.  10). Poly- 
somes fractionate with both Triton-soluble and -insoluble 
fractions, with the majority of the polysomes sedimenting 
with the Triton-insoluble fraction. The Triton-insoluble frac- 
tion, while enriched in cytoskeletal proteins, is also com- 
posed  of other  cellular structures  (Fig.  4)  and has been 
shown, in another cell, to contain polysomes (8). The betero- 
genicity of the Triton-soluble and -insoluble fractions prob- 
ably contributes to blurring the measurement of the move- 
ment of nascent spectrin from one compartment to the other. 
The results of the pulse-chase experiments, however,  are 
consistent with nascent tt and 13 spectrin leaving polysomes, 
which may be present either in the Triton-soluble or -insolu- 
ble fraction, mixing with a pool of preformed spectrin in the 
Triton-soluble fraction and later being incorporated, in equi- 
molar amounts, into the cytoskeletal framework. 
Immunocytochemical analysis, at the level of the electron 
microscope,  shows  that  the  majority  of the  spectrin  in 
DMSO-treated cells occurs in two locations; near the outer 
plasma  membrane and  associated with complex vacuolar 
structures which contain virus particles. This method does 
not distinguish between the pool of spectrin (that which oc- 
curs in the Triton-soluble fraction) and spectrin which is a 
component of the cytoskeletal system. Nor does it detect na- 
scent spectrin which is  newly incorporated into the cyto- 
skeletal system as opposed to preformed spectrin. The loca- 
tion of spectrin near the outer plasma membrane is consistent 
with its role in erythrocyte structure. The marked accumula- 
tion of spectrin in the vacuolar structures which contain virus 
is interesting, since it suggests that spectrin may be involved 
in the segregation and/or the budding of virus particles from 
the cell. 
In chicken erythroid cells, ~t and 13 spectrin and ankyrin, 
are synthesized in greater amounts than are needed for as- 
sembly into the cytoskeleton (23),  and this is particularly 
evident for ~t spectrin which is produced in threefold excess 
over 13 spectrin (4, 22). This has led to the conclusion that 
Table II. lmmunocytochemical Analysis of  Spectrin in Untreated and DMSO-treated Cells 
Percent particles 
Endoplasmic  Other 
DMSO  Total number  reticulum and  cytoplasmic  Complex 
treatment (days)  particles  Nucleus  Golgi region  areas  Mitochondria  vacuoles 
Plasma 
membranes 
0  305  4  26  32  3  3  32 
3  1,093  7  7  26  5  25  30 
5  766  4  6  8  4  57  21 
7  629  4  7  10  1  61  17 
The spectrin in untreated and DMSO-treated FELC was localized by immunocytochemistry  as described in Materials and Methods. In each sample, the number 
of gold particles in 40 cell profiles was counted. The number of particles in control samples, which were treated with preimmune rabbit IgG instead of antibody, 
was subtracted from the above figures. 
Pfeffer et al. Biosynthesis of Spectrin  111 Figure 12. Immunocytochemical localization of spectrin in DMSO-treated  cells.  FELC were immunochemically  labeled using affinity- 
purified rabbit antibody to human spectrin and goat anti-rabbit IgG coupled to 20-nm colloidal gold particles. A and B show representative 
fields of FELC treated for 3 d with DMSO; C shows cells treated for 5 d and D shows cells treated for 7 d. N, nucleus; PM, plasma mem- 
brane.  The complex vacuolar structures containing viruses are apparent in A, C, and D. Bar, 250 nm. 
the  molar ratios of the  component proteins present in the 
cytoskeleton are determined posttranslationally by the spe- 
cific attachment of proteins to each other and to the mem- 
brane skeleton,  rather than by the relative amounts of the 
component proteins which are synthesized (18). Band 3, an 
integral membrane protein, is thought to be a prerequisite for 
the attachment of cytoskeletal proteins to the plasma mem- 
brane (18, 23).  The finding that FELC and avian erythroid 
cells contain a pool of a  and ~ spectrin in the Triton-soluble 
fraction, but that the ratios of a  and [~ spectrin differ greatly 
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13 spectrin and in FELC there is 25 % more 13 than vt spectrin) 
is consistent with the view that the relative amounts of ¢t and 
13 spectrin synthesized do not regulate their assembly into the 
cytoskeletal system. FELC, when treated with DMSO, show 
a staggered increase in the synthesis of various red cell mem- 
brane components, with peak synthesis of band 3 occurring 
1 d after that of spectrin.  However, there is some synthesis 
of these proteins  throughout the entire period  of DMSO- 
induced differentiation,  and in fact,  synthesis of both band 
3 and spectrin can be noted in untreated FELC (24).  Thus, 
the protein components necessary for proper cytoskeletal as- 
sembly  are probably  always present in FELC.  We do not 
know however, what percent of the spectrin, synthesized by 
FELC, is assembled into a cytoskeletal system similar to that 
which  occurs  in  erythrocytes.  Our  immunocytochemical 
studies only note that the cellular location of spectrin shifts, 
during DMSO-induced differentiation,  and that after 5-7 d 
of DMSO treatment most of the spectrin is localized  near 
complex vacuoles which are associated with virus. 
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